Aclaris Therapeutics Announces Positive Results from Phase 2b Clinical Trial … – Business Wire (press release)
Aclaris Therapeutics Announces Positive Results from Phase 2b Clinical Trial …Business Wire (press release)In the trial, A-101 demonstrated clinically and statistically significant improvements in clearing multiple seborrheic keratoses (SK), one of the most common types of skin tumors. Though the lesions are benign, many patients elect to have SK treated …and more »
[monetize id=”1″]
[monetize id=”2″]
Are there OTC or prescription products to treat seborrheic …
What is seborrheic keratosis? – Medical News Today
What is seborrheic keratosis?Medical News TodayThe Mayo Clinic in the United States says that most insurance companies and Medicare do not pay for the removal of seborrheic keratoses if done just for cosmetic reasons. The British Association of Dermatologist also informs "Such treatments may not be …
